Cargando…
The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study
BACKGROUND: Interferon beta (IFNβ) and glatiramer acetate (GA) are administered by subcutaneous (SC) or intramuscular (IM) injection. Patients with multiple sclerosis (MS) often report injection-site reactions (ISRs) as a reason for noncompliance or switching therapies. The aim of this study was to...
Autores principales: | Beer, Karsten, Müller, Martin, Hew-Winzeler, Anna Marie, Bont, Adriano, Maire, Philippe, You, Xiaojun, Foulds, Pamela, Mårlind, Jessica, Curtius, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227610/ https://www.ncbi.nlm.nih.gov/pubmed/22074056 http://dx.doi.org/10.1186/1471-2377-11-144 |
Ejemplares similares
-
Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis
por: Earla, Jagadeswara R, et al.
Publicado: (2020) -
Injection-Site Reaction Following 5-Azacitidine Injection
por: Jun, Hee Jin, et al.
Publicado: (2014) -
REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : III. REACTIONS AT THE SITE OF INJECTION
por: Julianelle, Louis A.
Publicado: (1930) -
Tirzepatide-Induced Injection Site Reaction
por: Mizumoto, Junki
Publicado: (2023) -
Delayed local reaction at a previous injection site reaction with dupilumab
por: Sumi, Toshiyuki, et al.
Publicado: (2021)